RAPID POINT OF CARE TESTS FOR TUBERCULOSIS
$1,500,000N44FY2021AINIH
Zymeron Corporation, Durham NC
Investigators
Abstract
To develop an assay for therapeutic drug monitoring for tuberculosis treatments.
View original record on NIH RePORTER →Zymeron Corporation, Durham NC
To develop an assay for therapeutic drug monitoring for tuberculosis treatments.
View original record on NIH RePORTER →